Johnson & Johnson Vision introduces the CATALYS® System Mobile Patient Bed developed to help optimize patient workflow throughout the full cataract procedure

SANTA ANA, Calif. (October 7, 2017) – Johnson & Johnson Vision today announced that the CATALYS® System Mobile Patient Bed* has received FDA clearance for sale in the United States and will be available for sale in November. 

The Mobile Patient Bed is the latest addition for the CATALYS® Precision Laser System. Designed to optimize workflow from cataract patient preparation through postoperative recovery, the bed integrates seamlessly with the CATALYS® System through Bluetooth connectivity. The Mobile Patient Bed brings a new level of simplicity to laser cataract surgery and phacoemulsification workflow through an ergonomically designed headrest to optimize patient head positioning and an intuitive remote control pendant. Additionally, the ability to adapt the bed to multiple positions and back conditions helps to conform to patients’ individual physical needs and conditions. 

“Our goal with this innovation is to enhance patients’ overall surgical experience, so we worked to provide an easy transition as they move from one part of their cataract procedure to the next and premium comfort while they are in the operating room”, said Tom Frinzi, Worldwide President, Surgical Vision, at Johnson & Johnson Vision. “We also designed the mobility and adaptability features of this bed to help simplify the workflow for surgeons between the laser cataract suite and phacoemulsification.” 

Johnson & Johnson Vision 

Johnson & Johnson Vision is committed to improving and restoring sight for patients worldwide. Since debuting the world’s first disposable soft contact lens in 1987, it has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health. Serving more than 60 million patients a day across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 8,400 employees worldwide. 

# # # 

For further information, contact: 

Kara Peterson 
904-443-3480 (office) 
817-374-3960 (mobile) 

*AMO Manufacturing USA, LLC is the legal manufacturer of the CATALYS® System Mobile Patient Bed 

© 2017 Abbott Medical Optics, Inc. CATALYS is a trademark owned by or licensed to Abbott Medical Optics Inc., its subsidiaries or affiliates. All other trademarks are the intellectual property of their respective owners.